首页 > 最新文献

Northern Clinics of Istanbul最新文献

英文 中文
Relationship between glycosylated hemoglobin and vitamin B12 deficiency anemia. 糖化血红蛋白与维生素B12缺乏性贫血的关系。
IF 1 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2022-10-21 eCollection Date: 2022-01-01 DOI: 10.14744/nci.2022.76259
Bunyamin Aydin, Guven Baris Cansu, Can Ozlu

Objective: Previous studies showed that vitamin B12 deficiency anemia causes a false increase in glycosylated hemoglobin (HbA1c) and that HbA1c decreases with B12 treatment. However, no study has been conducted on how much an increase in hemoglobin (Hgb) level causes a decrease in HbA1c level after treatment.

Methods: The study included 37 patients who were not diagnosed with diabetes, did not use anti-diabetic drugs, were pre-diabetic according to HbA1c level, and were diagnosed with vitamin B12 deficiency anemia in the patient group and 40 healthy volunteers of similar age and gender characteristics in the control group. The patient group was given 1 mg/day of cyanocobalamin (vitamin B12) orally for 3 months. Patients' Hgb, mean corpuscular volume, fasting plasma glucose, HbA1c, and vitamin B12 values were compared at the beginning and at the end of the 3rd month.

Results: In the patient group, it was determined that 0.94 mg/dL increase in Hgb after vitamin B12 treatment caused a 0.24 decrease in HbA1c (%). The initial HbA1c of the patient group was 6.01±0.20 and the 3rd-month HbA1c was 5.77±0.33; the initial and 3rd-month Hgb values were 11.31±0.28 and 12.26±0.33, respectively; the initial and 3rd-month vitamin B12 (ng/L) levels were 112.43±7.18 and 408.48±119.61, respectively; and there was a significant difference between the initial and 3rd-month values (p<0.001, p<0.001, p<0.001, respectively). Moreover, 35% of the patients in the patient group had no diagnosis of prediabetes according to the HbA1c level at the end of the 3rd month.

Conclusion: Elimination of vitamin B12 deficiency anemia before making a diagnosis or treatment decision according to HbA1c level will prevent patients from misdiagnosis of diabetes and unnecessary treatment changes in diabetic patients.

目的:以往的研究表明,维生素B12缺乏性贫血会导致糖化血红蛋白(HbA1c)的假升高,并且HbA1c随维生素B12治疗而降低。然而,治疗后血红蛋白(Hgb)水平升高多少会导致HbA1c水平下降,目前还没有研究。方法:患者组为37例未确诊为糖尿病、未使用抗糖尿病药物、根据HbA1c水平诊断为糖尿病前期、诊断为维生素B12缺乏性贫血的患者,对照组为40例年龄、性别特征相近的健康志愿者。患者组给予氰钴胺素(维生素B12) 1 mg/d口服,疗程3个月。比较患者在第3个月开始和结束时的Hgb、平均红细胞体积、空腹血糖、HbA1c和维生素B12值。结果:在患者组中,确定维生素B12治疗后Hgb增加0.94 mg/dL导致HbA1c降低0.24(%)。患者组初始HbA1c为6.01±0.20,第3个月HbA1c为5.77±0.33;初始和第3个月Hgb值分别为11.31±0.28和12.26±0.33;初始和第3个月维生素B12 (ng/L)水平分别为112.43±7.18和408.48±119.61;第3个月的数值与第3个月的数值有显著性差异。结论:在根据HbA1c水平作出诊断或治疗决定前消除维生素B12缺乏性贫血,可防止患者误诊糖尿病,避免糖尿病患者不必要的治疗改变。
{"title":"Relationship between glycosylated hemoglobin and vitamin B12 deficiency anemia.","authors":"Bunyamin Aydin,&nbsp;Guven Baris Cansu,&nbsp;Can Ozlu","doi":"10.14744/nci.2022.76259","DOIUrl":"https://doi.org/10.14744/nci.2022.76259","url":null,"abstract":"<p><strong>Objective: </strong>Previous studies showed that vitamin B12 deficiency anemia causes a false increase in glycosylated hemoglobin (HbA1c) and that HbA1c decreases with B12 treatment. However, no study has been conducted on how much an increase in hemoglobin (Hgb) level causes a decrease in HbA1c level after treatment.</p><p><strong>Methods: </strong>The study included 37 patients who were not diagnosed with diabetes, did not use anti-diabetic drugs, were pre-diabetic according to HbA1c level, and were diagnosed with vitamin B12 deficiency anemia in the patient group and 40 healthy volunteers of similar age and gender characteristics in the control group. The patient group was given 1 mg/day of cyanocobalamin (vitamin B12) orally for 3 months. Patients' Hgb, mean corpuscular volume, fasting plasma glucose, HbA1c, and vitamin B12 values were compared at the beginning and at the end of the 3<sup>rd</sup> month.</p><p><strong>Results: </strong>In the patient group, it was determined that 0.94 mg/dL increase in Hgb after vitamin B12 treatment caused a 0.24 decrease in HbA1c (%). The initial HbA1c of the patient group was 6.01±0.20 and the 3<sup>rd</sup>-month HbA1c was 5.77±0.33; the initial and 3<sup>rd</sup>-month Hgb values were 11.31±0.28 and 12.26±0.33, respectively; the initial and 3<sup>rd</sup>-month vitamin B12 (ng/L) levels were 112.43±7.18 and 408.48±119.61, respectively; and there was a significant difference between the initial and 3<sup>rd</sup>-month values (p<0.001, p<0.001, p<0.001, respectively). Moreover, 35% of the patients in the patient group had no diagnosis of prediabetes according to the HbA1c level at the end of the 3<sup>rd</sup> month.</p><p><strong>Conclusion: </strong>Elimination of vitamin B12 deficiency anemia before making a diagnosis or treatment decision according to HbA1c level will prevent patients from misdiagnosis of diabetes and unnecessary treatment changes in diabetic patients.</p>","PeriodicalId":19164,"journal":{"name":"Northern Clinics of Istanbul","volume":"9 5","pages":"459-463"},"PeriodicalIF":1.0,"publicationDate":"2022-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/11/d5/NCI-9-459.PMC9677059.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40711906","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Does the severity of diabetic ketoacidosis in children with type 1 diabetes change during the COVID-19 pandemic? A single-center experience from a pediatric intensive care unit. 在COVID-19大流行期间,1型糖尿病儿童糖尿病酮症酸中毒的严重程度是否会发生变化?来自儿科重症监护病房的单中心体验。
IF 1 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2022-10-20 eCollection Date: 2022-01-01 DOI: 10.14744/nci.2022.09634
Fatih Varol, Leyla Gizem Bolac Ozyilmaz, Ebru Guney Sahin, Yasar Yusuf Can, Ugur Altas, Halit Cam

Objective: During the COVID-19 pandemic, health-care services for diseases other than COVID-19 were interrupted, and patient referrals to health institutions were postponed due to their fear of being infected with COVID-19. Under this situation, we conducted this study to evaluate the clinical and laboratory findings of COVID-19 in patients with Type 1 Diabetes Mellitus (T1DM) hospitalized in our pediatric intensive care unit (PICU) with the diagnosis of diabetic ketoacidosis (DKA) during the pandemic period, and the impact of the pandemic on these findings.

Methods: We retrospectively evaluated 55 children aged from 1 month to 18 years old, diagnosed with DKA, and followed up at Istanbul Sehit Prof. Dr. Ilhan Varank Sancaktepe Training and Research Hospital PICU between April 2020 and December 2021.

Results: A total of 55 patients with DKA as a complication of T1DM were admitted to the PICU during the COVID-19 pandemic. While there was no significant difference in pH and HCO3 values between those with newly diagnosed T1DM and those with previously-diagnosed T1DM, the HbA1c ratio of newly diagnosed DMs was significantly higher. Of the 55 patients, 4 were COVID-19 PCR positive, and two patients had COVID-19 antibody positivity. When COVID-19 positive patients were compared with negative patients, no significant difference was found between the hospital stay, glucose, HbA1c, lactate, pH, and HCO3 values.

Conclusion: Higher HbA1c levels of newly diagnosed patients presenting with DKA may be associated with delayed admission to the health institutions due to COVID-19 and the length of insulin-free periods compared to pre-diagnosed patients with T1DM. In conclusion, our results, emphasize the importance of physician's and family's awareness of the symptoms of diabetes in terms of early diagnosis and prevention of DKA during public health measures due to COVID-19.

目的:在2019冠状病毒病大流行期间,由于患者担心感染新冠病毒,导致非COVID-19疾病的卫生保健服务中断,患者推迟转诊。在这种情况下,我们开展了本研究,以评估大流行期间在我儿科重症监护病房(PICU)住院的诊断为糖尿病酮症酸中毒(DKA)的1型糖尿病(T1DM)患者的COVID-19临床和实验室结果,以及大流行对这些结果的影响。方法:我们回顾性评估了55名年龄在1个月至18岁之间,被诊断为DKA的儿童,并于2020年4月至2021年12月在伊斯坦布尔Sehit教授Ilhan Varank sanaktepe培训和研究医院PICU进行了随访。结果:在COVID-19大流行期间,共有55例合并T1DM的DKA患者入住PICU。虽然新诊断T1DM患者的pH值和HCO3值与既往T1DM患者无显著差异,但新诊断dm患者的HbA1c比值明显较高。55例患者中,PCR阳性4例,抗体阳性2例。当COVID-19阳性患者与阴性患者比较时,住院时间、葡萄糖、HbA1c、乳酸、pH和HCO3值无显著差异。结论:与T1DM患者相比,新诊断DKA患者HbA1c水平较高可能与COVID-19延迟入院时间和无胰岛素时间有关。总之,我们的研究结果强调了医生和家庭对糖尿病症状的认识对于在COVID-19引起的公共卫生措施中早期诊断和预防DKA的重要性。
{"title":"Does the severity of diabetic ketoacidosis in children with type 1 diabetes change during the COVID-19 pandemic? A single-center experience from a pediatric intensive care unit.","authors":"Fatih Varol,&nbsp;Leyla Gizem Bolac Ozyilmaz,&nbsp;Ebru Guney Sahin,&nbsp;Yasar Yusuf Can,&nbsp;Ugur Altas,&nbsp;Halit Cam","doi":"10.14744/nci.2022.09634","DOIUrl":"https://doi.org/10.14744/nci.2022.09634","url":null,"abstract":"<p><strong>Objective: </strong>During the COVID-19 pandemic, health-care services for diseases other than COVID-19 were interrupted, and patient referrals to health institutions were postponed due to their fear of being infected with COVID-19. Under this situation, we conducted this study to evaluate the clinical and laboratory findings of COVID-19 in patients with Type 1 Diabetes Mellitus (T1DM) hospitalized in our pediatric intensive care unit (PICU) with the diagnosis of diabetic ketoacidosis (DKA) during the pandemic period, and the impact of the pandemic on these findings.</p><p><strong>Methods: </strong>We retrospectively evaluated 55 children aged from 1 month to 18 years old, diagnosed with DKA, and followed up at Istanbul Sehit Prof. Dr. Ilhan Varank Sancaktepe Training and Research Hospital PICU between April 2020 and December 2021.</p><p><strong>Results: </strong>A total of 55 patients with DKA as a complication of T1DM were admitted to the PICU during the COVID-19 pandemic. While there was no significant difference in pH and HCO<sub>3</sub> values between those with newly diagnosed T1DM and those with previously-diagnosed T1DM, the HbA1c ratio of newly diagnosed DMs was significantly higher. Of the 55 patients, 4 were COVID-19 PCR positive, and two patients had COVID-19 antibody positivity. When COVID-19 positive patients were compared with negative patients, no significant difference was found between the hospital stay, glucose, HbA1c, lactate, pH, and HCO<sub>3</sub> values.</p><p><strong>Conclusion: </strong>Higher HbA1c levels of newly diagnosed patients presenting with DKA may be associated with delayed admission to the health institutions due to COVID-19 and the length of insulin-free periods compared to pre-diagnosed patients with T1DM. In conclusion, our results, emphasize the importance of physician's and family's awareness of the symptoms of diabetes in terms of early diagnosis and prevention of DKA during public health measures due to COVID-19.</p>","PeriodicalId":19164,"journal":{"name":"Northern Clinics of Istanbul","volume":"9 5","pages":"429-435"},"PeriodicalIF":1.0,"publicationDate":"2022-10-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/39/c0/NCI-9-429.PMC9677060.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40711907","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Thyroid functions in patients with hypochondriasis. 疑病症患者的甲状腺功能。
IF 1 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2022-10-20 eCollection Date: 2022-01-01 DOI: 10.14744/nci.2022.67365
Mustafa Nuray Namli, Sema Baykara, Murad Atmaca

Objective: No studies of thyroid-related hormone levels have been conducted in patients with hypochondriasis to date. The aim of this study is to examine thyroid-related hormones in patients with hypochondriasis.

Methods: Sixty patients with hypochondriasis and 138 healthy controls were included in this study. Patients with hypochondriasis who applied to the psychiatry outpatient clinic and met the study criteria and healthy controls were determined by chart analysis.

Results: According to the results of the comparisons, TSH, fT3, and fT4 levels did not show a statistically significant difference between hypochondriasis patients and healthy controls.

Conclusion: Thyroid hormone levels are not associated with hypochondriasis.

目的:迄今为止,尚无关于疑病症患者甲状腺相关激素水平的研究。本研究旨在探讨疑病症患者甲状腺相关激素的变化。方法:选取60例疑病症患者和138例健康对照进行研究。采用图表分析确定到精神科门诊就诊并符合研究标准的疑病症患者和健康对照。结果:比较结果显示,疑病症患者TSH、fT3、fT4水平与健康对照无统计学差异。结论:甲状腺激素水平与疑病症无关。
{"title":"Thyroid functions in patients with hypochondriasis.","authors":"Mustafa Nuray Namli,&nbsp;Sema Baykara,&nbsp;Murad Atmaca","doi":"10.14744/nci.2022.67365","DOIUrl":"https://doi.org/10.14744/nci.2022.67365","url":null,"abstract":"<p><strong>Objective: </strong>No studies of thyroid-related hormone levels have been conducted in patients with hypochondriasis to date. The aim of this study is to examine thyroid-related hormones in patients with hypochondriasis.</p><p><strong>Methods: </strong>Sixty patients with hypochondriasis and 138 healthy controls were included in this study. Patients with hypochondriasis who applied to the psychiatry outpatient clinic and met the study criteria and healthy controls were determined by chart analysis.</p><p><strong>Results: </strong>According to the results of the comparisons, TSH, fT3, and fT4 levels did not show a statistically significant difference between hypochondriasis patients and healthy controls.</p><p><strong>Conclusion: </strong>Thyroid hormone levels are not associated with hypochondriasis.</p>","PeriodicalId":19164,"journal":{"name":"Northern Clinics of Istanbul","volume":"9 5","pages":"436-438"},"PeriodicalIF":1.0,"publicationDate":"2022-10-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/4c/5c/NCI-9-436.PMC9677053.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40711840","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Investigation of respiratory tract coinfections in Coronavirus disease 2019 infected and suspected cases. 2019冠状病毒病感染和疑似病例呼吸道合并感染调查
IF 1 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2022-10-20 eCollection Date: 2022-01-01 DOI: 10.14744/nci.2022.82608
Habip Yilmaz, Arzu Irvem, Abdullah Emre Guner, Cemal Kazezoglu, Ali Kocatas

Objective: The aim of our study is to determine the risk of coinfection with COVID-19 due to the high prevalence of viral agents in Istanbul in autumn (September, October, and November) and winter (December and January) and to investigate the effects of age, gender, season and clinical features on the development of coinfection with COVID-19.

Methods: In the routine studies of our hospital, COVID-19, reverse transcriptase polymerase chain reaction (RTA kit, Turkiye) and Multiplex PCR Bio-Fire (Bio Merieux Company, France) methods were studied from the nasopharyngeal swab sample and the data were recorded. A total of 400 people with a mean age (7.91±17.80) were included in the study by retrospective scanning.

Results: Considering the virus distribution, Respiratory syncytial virus (RSV), COVID-19, rhino/entero virus did not show a significant difference in autumn and winter, while H. metapneumovirus, adeno virus, influenza A significantly higher rates were observed in winter months. Parainfluenza (1, 2, 3, 4) and Corona OC43 were detected at a higher rate in autumn compared to other viruses. Double and triple coinfection rates with other viral agents were high for 2 years and younger.

Conclusion: The risk of coinfection of COVID-19 with influenza A, RSV, parainfluenza, and rhino/entero virus was found to be higher than other viral agents. Especially in winter, the risk of coinfection with influenza A and COVID-19 increases. In terms of treatment management, coinfection should be investigated in risky patients and influenza a vaccine should be offered to risky groups.

目的:本研究旨在确定伊斯坦布尔秋季(9月、10月和11月)和冬季(12月和1月)病毒药物高发导致合并感染COVID-19的风险,并探讨年龄、性别、季节和临床特征对合并感染的影响。方法:在我院常规研究中,采用逆转录酶聚合酶链反应(RTA kit, Turkiye)和Bio- fire (Bio - Merieux Company,法国)多重PCR法对鼻咽拭子样本进行COVID-19检测,并记录数据。采用回顾性扫描方法,共纳入平均年龄(7.91±17.80)例400例。结果:从病毒分布来看,呼吸道合胞病毒(RSV)、新冠病毒(COVID-19)、犀牛/肠病毒(rhino/entero virus)在秋冬季节的感染率无显著差异,而偏肺嗜血杆菌病毒(H. metappneumavirus)、腺病毒(adeno virus)、甲型流感(influenza a)的感染率在冬季显著升高。副流感病毒(1、2、3、4)和冠状病毒OC43在秋季的检出率高于其他病毒。2岁及以下患者与其他病毒制剂的双重和三重合并感染率较高。结论:新型冠状病毒感染甲型流感、RSV、副流感和犀牛/肠病毒的风险高于其他病毒病原体。特别是在冬季,同时感染甲型流感和COVID-19的风险增加。在治疗管理方面,应调查高危患者的合并感染情况,并向高危人群提供甲型流感疫苗。
{"title":"Investigation of respiratory tract coinfections in Coronavirus disease 2019 infected and suspected cases.","authors":"Habip Yilmaz,&nbsp;Arzu Irvem,&nbsp;Abdullah Emre Guner,&nbsp;Cemal Kazezoglu,&nbsp;Ali Kocatas","doi":"10.14744/nci.2022.82608","DOIUrl":"https://doi.org/10.14744/nci.2022.82608","url":null,"abstract":"<p><strong>Objective: </strong>The aim of our study is to determine the risk of coinfection with COVID-19 due to the high prevalence of viral agents in Istanbul in autumn (September, October, and November) and winter (December and January) and to investigate the effects of age, gender, season and clinical features on the development of coinfection with COVID-19.</p><p><strong>Methods: </strong>In the routine studies of our hospital, COVID-19, reverse transcriptase polymerase chain reaction (RTA kit, Turkiye) and Multiplex PCR Bio-Fire (Bio Merieux Company, France) methods were studied from the nasopharyngeal swab sample and the data were recorded. A total of 400 people with a mean age (7.91±17.80) were included in the study by retrospective scanning.</p><p><strong>Results: </strong>Considering the virus distribution, Respiratory syncytial virus (RSV), COVID-19, rhino/entero virus did not show a significant difference in autumn and winter, while H. metapneumovirus, adeno virus, influenza A significantly higher rates were observed in winter months. Parainfluenza (1, 2, 3, 4) and Corona OC43 were detected at a higher rate in autumn compared to other viruses. Double and triple coinfection rates with other viral agents were high for 2 years and younger.</p><p><strong>Conclusion: </strong>The risk of coinfection of COVID-19 with influenza A, RSV, parainfluenza, and rhino/entero virus was found to be higher than other viral agents. Especially in winter, the risk of coinfection with influenza A and COVID-19 increases. In terms of treatment management, coinfection should be investigated in risky patients and influenza a vaccine should be offered to risky groups.</p>","PeriodicalId":19164,"journal":{"name":"Northern Clinics of Istanbul","volume":"9 5","pages":"421-428"},"PeriodicalIF":1.0,"publicationDate":"2022-10-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/9b/67/NCI-9-421.PMC9677056.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40711846","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The effects of IL28B rs12979860 and rs8099917 polymorphism on hepatitis B infection. il - 28b rs12979860和rs8099917多态性对乙型肝炎感染的影响。
IF 1 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2022-10-20 eCollection Date: 2022-01-01 DOI: 10.14744/nci.2022.37542
Bulent Cakal, Bilger Cavus, Alp Atasoy, Damla Altunok, Mehves Poda, Mesut Bulakci, Mine Gulluoglu, Mehmet Demirci, Leyla Turker Sener, Asli Berru Arslan, Filiz Akyuz

Objective: The purpose of this study was to evaluate the relationship of IL28B rs12979860 and rs8099917 polymorphisms with the clinical, histological, and virological outcomes of patients with chronic hepatitis B (CHB) also the treatment responses of patients who received Nucleos(t)ide analogs (NAs) therapy.

Methods: This study included 152 CHB patients who were underwent liver parenchymal biopsy. The IL28B rs12979860 and rs8099917 polymorphism were genotyped using the TaqMan assay.

Results: The IL28B rs12979860 CC and IL28B rs8099917 TT were identified as the genotypes with the highest frequency in all patients. On the other hand, IL28B rs12979860 TT and IL28B rs8099917 GG were the genotypes with the lowest frequency. The frequency of IL28B rs8099917 TG genotype was significantly different between patients with hepatitis B, who has histologically defined liver cirrhosis and no-fibrosis (p=0.02). In addition, a statistically significant correlation was found between the presence of IL28B rs8099917 G allele and virological unresponsiveness to NAs treatments in CHB patients (p=0.028).

Conclusion: The presence of the IL28B rs8099917 G allele in CHB patients might be associated with the risk of developing cirrhosis and virological unresponsiveness to NAs treatments.

目的:本研究的目的是评估IL28B rs12979860和rs8099917多态性与慢性乙型肝炎(CHB)患者的临床、组织学和病毒学结局以及接受核酸(t)ide类似物(NAs)治疗的患者的治疗反应的关系。方法:152例慢性乙型肝炎患者行肝实质活检。采用TaqMan法对IL28B rs12979860和rs8099917多态性进行基因分型。结果:IL28B rs12979860 CC和IL28B rs8099917 TT是所有患者中频率最高的基因型。另一方面,IL28B rs12979860 TT和IL28B rs8099917 GG是出现频率最低的基因型。在组织学定义为肝硬化和无纤维化的乙型肝炎患者中,IL28B rs8099917 TG基因型的频率差异有统计学意义(p=0.02)。此外,IL28B rs8099917 G等位基因的存在与CHB患者对NAs治疗的病毒学无应答之间存在统计学意义上的相关性(p=0.028)。结论:慢性乙型肝炎患者中IL28B rs8099917 G等位基因的存在可能与发生肝硬化的风险和对NAs治疗的病毒学无反应有关。
{"title":"The effects of IL28B rs12979860 and rs8099917 polymorphism on hepatitis B infection.","authors":"Bulent Cakal,&nbsp;Bilger Cavus,&nbsp;Alp Atasoy,&nbsp;Damla Altunok,&nbsp;Mehves Poda,&nbsp;Mesut Bulakci,&nbsp;Mine Gulluoglu,&nbsp;Mehmet Demirci,&nbsp;Leyla Turker Sener,&nbsp;Asli Berru Arslan,&nbsp;Filiz Akyuz","doi":"10.14744/nci.2022.37542","DOIUrl":"https://doi.org/10.14744/nci.2022.37542","url":null,"abstract":"<p><strong>Objective: </strong>The purpose of this study was to evaluate the relationship of IL28B rs12979860 and rs8099917 polymorphisms with the clinical, histological, and virological outcomes of patients with chronic hepatitis B (CHB) also the treatment responses of patients who received Nucleos(t)ide analogs (NAs) therapy.</p><p><strong>Methods: </strong>This study included 152 CHB patients who were underwent liver parenchymal biopsy. The IL28B rs12979860 and rs8099917 polymorphism were genotyped using the TaqMan assay.</p><p><strong>Results: </strong>The IL28B rs12979860 CC and IL28B rs8099917 TT were identified as the genotypes with the highest frequency in all patients. On the other hand, IL28B rs12979860 TT and IL28B rs8099917 GG were the genotypes with the lowest frequency. The frequency of IL28B rs8099917 TG genotype was significantly different between patients with hepatitis B, who has histologically defined liver cirrhosis and no-fibrosis (p=0.02). In addition, a statistically significant correlation was found between the presence of IL28B rs8099917 G allele and virological unresponsiveness to NAs treatments in CHB patients (p=0.028).</p><p><strong>Conclusion: </strong>The presence of the IL28B rs8099917 G allele in CHB patients might be associated with the risk of developing cirrhosis and virological unresponsiveness to NAs treatments.</p>","PeriodicalId":19164,"journal":{"name":"Northern Clinics of Istanbul","volume":"9 5","pages":"439-444"},"PeriodicalIF":1.0,"publicationDate":"2022-10-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/d3/12/NCI-9-439.PMC9677046.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40711903","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Parent rated bedtime resistance and comorbidity may predict levels of attention among Turkish children diagnosed with ADHD in on-line education classes during the COVID-19 outbreak. COVID-19疫情爆发期间,在在线教育班级中被诊断患有多动症的土耳其儿童的注意力水平可能会受到家长就寝抵抗力和合并症的影响。
IF 0.9 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2022-10-19 eCollection Date: 2023-01-01 DOI: 10.14744/nci.2022.77674
Yusuf Ozturk, Gonca Ozyurt, Vahdet Gormez, Zeynep Dilara Aslankaya, Burak Baykara, Ozalp Ekinci, Ilyas Kaya, Ibrahim Adak, Ibrahim Selcuk Esin, Serkan Turan, Mesut Sari, Guler Gol Ozcan, Cagatay Ermis, Nazan Ekinci, Ozge Ipek Dogan, Ibrahim Tiryaki, Sureyyanur Kitapcioglu, Ali Evren Tufan, Neslihan Inal, Aynur Pekcanlar Akay

Objective: This study aimed to compare the attention levels, of Turkish children and adolescents with Attention Deficit/ Hyperactivity Disorder (ADHD) in on-line education classes with healthy controls.

Methods: This study is a cross-sectional, internet-based, case-control study that recruited 6-18 years old patients diagnosed with ADHD and receving treatment and healthy controls from eight centers. The measurements used in the study were prepared in the google survey and delivered to the participants via Whatsapp application.

Results: Within the study period, 510 children with ADHD and 893 controls were enrolled. Parent- rated attention decreased significantly in both groups during on-line education classes due to COVID-19 outbreak (p<0.001; for each). Children and adolescents with ADHD had significantly elevated bedtime resistance, problems in family functioning difficulties than control children according to parental reports (p=0.003; p<0.001; p<0.001, respectively). Furthermore, bedtime resistance and comorbidity significantly predicted attention levels in on-line education.

Conclusion: Our findings may underline the need to augment student engagement in on-line education both for children without attention problems and those with ADHD. Interventions shown to be effective in the management of sleep difficulties in children as well as parent management interventions should continue during on-line education.

研究目的本研究旨在比较在线教育课程中患有注意力缺陷/多动症(ADHD)的土耳其儿童和青少年与健康对照组的注意力水平:本研究是一项基于互联网的病例对照横断面研究,招募了来自八个中心的 6-18 岁被诊断为多动症并正在接受治疗的患者和健康对照者。研究中使用的测量方法是在谷歌调查中准备的,并通过 Whatsapp 应用程序发送给参与者:在研究期间,共有 510 名多动症儿童和 893 名对照组儿童参加了研究。在在线教育课程中,由于 COVID-19 的爆发,两组儿童的家长评定注意力都明显下降(p结论:我们的研究结果可能会强调,需要对多动症儿童进行更多的干预:我们的研究结果表明,无论是对于没有注意力问题的儿童还是患有多动症的儿童,都有必要提高学生在在线教育中的参与度。在在线教育期间,应继续采取已证明有效的儿童睡眠障碍管理干预措施和家长管理干预措施。
{"title":"Parent rated bedtime resistance and comorbidity may predict levels of attention among Turkish children diagnosed with ADHD in on-line education classes during the COVID-19 outbreak.","authors":"Yusuf Ozturk, Gonca Ozyurt, Vahdet Gormez, Zeynep Dilara Aslankaya, Burak Baykara, Ozalp Ekinci, Ilyas Kaya, Ibrahim Adak, Ibrahim Selcuk Esin, Serkan Turan, Mesut Sari, Guler Gol Ozcan, Cagatay Ermis, Nazan Ekinci, Ozge Ipek Dogan, Ibrahim Tiryaki, Sureyyanur Kitapcioglu, Ali Evren Tufan, Neslihan Inal, Aynur Pekcanlar Akay","doi":"10.14744/nci.2022.77674","DOIUrl":"10.14744/nci.2022.77674","url":null,"abstract":"<p><strong>Objective: </strong>This study aimed to compare the attention levels, of Turkish children and adolescents with Attention Deficit/ Hyperactivity Disorder (ADHD) in on-line education classes with healthy controls.</p><p><strong>Methods: </strong>This study is a cross-sectional, internet-based, case-control study that recruited 6-18 years old patients diagnosed with ADHD and receving treatment and healthy controls from eight centers. The measurements used in the study were prepared in the google survey and delivered to the participants via Whatsapp application.</p><p><strong>Results: </strong>Within the study period, 510 children with ADHD and 893 controls were enrolled. Parent- rated attention decreased significantly in both groups during on-line education classes due to COVID-19 outbreak (p<0.001; for each). Children and adolescents with ADHD had significantly elevated bedtime resistance, problems in family functioning difficulties than control children according to parental reports (p=0.003; p<0.001; p<0.001, respectively). Furthermore, bedtime resistance and comorbidity significantly predicted attention levels in on-line education.</p><p><strong>Conclusion: </strong>Our findings may underline the need to augment student engagement in on-line education both for children without attention problems and those with ADHD. Interventions shown to be effective in the management of sleep difficulties in children as well as parent management interventions should continue during on-line education.</p>","PeriodicalId":19164,"journal":{"name":"Northern Clinics of Istanbul","volume":"10 2","pages":"197-204"},"PeriodicalIF":0.9,"publicationDate":"2022-10-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/6d/6a/NCI-10-197.PMC10170383.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9822348","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Isolated abducens nerve palsy: Comparison of microvascular and other causes. 孤立性外展神经麻痹:微血管与其他病因的比较。
IF 1 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2022-09-05 eCollection Date: 2022-01-01 DOI: 10.14744/nci.2021.15483
Yuksel Erdal, Taskin Gunes, Ufuk Emre

Objective: Abducens nerve paralysis is the most common ocular motor neuropathy. In this article, we aimed to compare the causes of isolated abducens nerve palsy in terms of demographic, clinical features, and prognosis.

Methods: Thirty-six isolated abducens nerve palsy patients were prospectively enrolled in the study. The demographic, clinical features, and prognosis compared in two etiological groups as microvascular and other causes.

Results: The most common etiology was microvascular, which was seen in 16/36 (44.4%) patients. Mean clinical recovery time was 2.5±1.3 months (range, 10 days-6 months). When etiological groups were compared as microvascular and other causes, the mean age of the microvascular group was significantly higher (62.8±13.3 vs. 44.5±16.4, p=0.001). Diabetes mellitus was seen significantly higher in the microvascular group than other causes group (p=0.001), but no significant difference was observed in terms of other atherosclerotic risk factors (p>0.05). The fasting blood glucose and hemoglobin A1c value were significantly higher in the microvascular group (p=0.02 and p=0.02, respectively). There was no significant difference in terms of clinical improvement and clinical recovery times between groups (p>0.05).

Conclusion: There is no difference between microvascular group and other causes in terms of clinical outcome, while the mean age and presence of diabetes were higher in the microvascular group. The presence of diabetes should be questioned in cases with isolated abducens nerve palsy.

目的:展外神经麻痹是最常见的眼运动神经病变。在这篇文章中,我们的目的是比较孤立性外展神经麻痹的人口学、临床特征和预后的原因。方法:对36例孤立性外展神经麻痹患者进行前瞻性研究。两组病因的人口学、临床特征和预后比较:微血管和其他病因。结果:微血管是最常见的病因,占16/36(44.4%)。平均临床恢复时间2.5±1.3个月(范围:10天-6个月)。当病因组以微血管组与其他病因组比较时,微血管组的平均年龄明显增高(62.8±13.3比44.5±16.4,p=0.001)。微血管组糖尿病发生率明显高于其他原因组(p=0.001),其他动脉粥样硬化危险因素差异无统计学意义(p>0.05)。微血管组空腹血糖和血红蛋白A1c值显著高于对照组(p=0.02和p=0.02)。两组患者的临床改善和临床恢复时间比较,差异无统计学意义(p>0.05)。结论:微血管组与其他原因组在临床转归上无差异,但微血管组的平均年龄和糖尿病存在率较高。孤立性外展神经麻痹患者是否存在糖尿病应予以怀疑。
{"title":"Isolated abducens nerve palsy: Comparison of microvascular and other causes.","authors":"Yuksel Erdal,&nbsp;Taskin Gunes,&nbsp;Ufuk Emre","doi":"10.14744/nci.2021.15483","DOIUrl":"https://doi.org/10.14744/nci.2021.15483","url":null,"abstract":"<p><strong>Objective: </strong>Abducens nerve paralysis is the most common ocular motor neuropathy. In this article, we aimed to compare the causes of isolated abducens nerve palsy in terms of demographic, clinical features, and prognosis.</p><p><strong>Methods: </strong>Thirty-six isolated abducens nerve palsy patients were prospectively enrolled in the study. The demographic, clinical features, and prognosis compared in two etiological groups as microvascular and other causes.</p><p><strong>Results: </strong>The most common etiology was microvascular, which was seen in 16/36 (44.4%) patients. Mean clinical recovery time was 2.5±1.3 months (range, 10 days-6 months). When etiological groups were compared as microvascular and other causes, the mean age of the microvascular group was significantly higher (62.8±13.3 vs. 44.5±16.4, p=0.001). Diabetes mellitus was seen significantly higher in the microvascular group than other causes group (p=0.001), but no significant difference was observed in terms of other atherosclerotic risk factors (p>0.05). The fasting blood glucose and hemoglobin A1c value were significantly higher in the microvascular group (p=0.02 and p=0.02, respectively). There was no significant difference in terms of clinical improvement and clinical recovery times between groups (p>0.05).</p><p><strong>Conclusion: </strong>There is no difference between microvascular group and other causes in terms of clinical outcome, while the mean age and presence of diabetes were higher in the microvascular group. The presence of diabetes should be questioned in cases with isolated abducens nerve palsy.</p>","PeriodicalId":19164,"journal":{"name":"Northern Clinics of Istanbul","volume":"9 4","pages":"353-357"},"PeriodicalIF":1.0,"publicationDate":"2022-09-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/1e/c1/NCI-9-353.PMC9514074.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40676057","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Direct cost analysis for 32,783 samples with preanalytical phase errors. 32,783个样品分析前相误差的直接成本分析。
IF 1 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2022-09-05 eCollection Date: 2022-01-01 DOI: 10.14744/nci.2022.73555
Pinar Eker

Objective: Errors in the laboratory process often occur in the preanalytical phase (PA). The study aims to calculate the direct cost elements of PA errors, including material, logistics, transfer, personnel workforce, and medical waste.

Methods: Medical laboratory PA phase errors were retrospectively reviewed using the Laboratory Information Management System. We evaluated the whole 2019 laboratory data of the 836-bed Health Sciences University Umraniye Training and Research Hospital (UTRH). We assessed the direct cost elements of PA errors, such as those related to material, logistics, transfer, human resources, and waste. We performed the procedure for both samples analyzed in the hospital and transferred to the central laboratory.

Results: We analyzed 1,939,650 patient samples and 46,534,532 parameters studied in 2019 for UTRH. The rates for rejected tests and rejected samples (tube) for UTRH were noted as 0.32% and 1.7%, respectively. The total direct cost for PA errors was TRY 438,284.51 (68,918.07 euros) for 32,783 patient samples and 147,893 tests. We calculated the total cost for PA test errors detected in the hospital as TRY 390,238.06, while the total cost for PA test errors detected in the central laboratory was TRY 48,046.45. 89% of the total cost was for PA errors detected in the hospital, and 11% was for the errors detected in the central laboratory. The 2019 direct PA error cost we calculated based on our hospital's data was 0.153% of the 2019 hospital operating cost. We calculated the direct cost per rejected sample as TRY 13.37 (2.1 Euro).

Conclusion: Providing reliable laboratory service with the least possible financial loss is one of the main goals in terms of laboratory medicine. In achieving this goal, the prevention of error costs is a priority. The direct cost elements for the PA phase, where laboratory errors are concentrated, can be easily identified. The amount of PA phase error direct cost will attract the attention of health policy decision-makers and field professionals and inspire further research. Therefore, we tried to determine a threshold cost regarding interventions and practices required to prevent PA phase errors.

目的:分析前阶段(PA)是实验室过程中经常发生的错误。本研究旨在计算PA错误的直接成本要素,包括材料,物流,转移,人员劳动力和医疗浪费。方法:利用实验室信息管理系统对医学实验室PA相位误差进行回顾性分析。我们评估了拥有836张床位的乌拉尼耶健康科学大学培训与研究医院(UTRH) 2019年的全部实验室数据。我们评估了PA错误的直接成本要素,例如与材料、物流、转移、人力资源和浪费相关的成本要素。我们在医院对两个样本进行了分析,并将其转移到中心实验室。结果:我们分析了2019年UTRH的1,939,650例患者样本和46,534,532个参数。UTRH试验不合格率和样品(管)不合格率分别为0.32%和1.7%。在32,783例患者样本和147,893次测试中,PA错误的总直接成本为438,284.51欧元(68,918.07欧元)。我们计算出医院检测到的PA检测错误总成本为TRY 390,238.06,而中心实验室检测到的PA检测错误总成本为TRY 48,046.45。总成本的89%用于医院检测到的PA错误,11%用于中心实验室检测到的错误。我们根据我院数据计算的2019年直接PA错误成本为2019年医院运营成本的0.153%。我们计算出每个不合格样品的直接成本为13.37欧元(2.1欧元)。结论:以最小的经济损失提供可靠的检验服务是检验医学的主要目标之一。为了实现这一目标,预防错误成本是一个优先事项。实验室误差集中的PA阶段的直接成本因素可以很容易地确定。PA相位误差直接成本的数额将引起卫生政策决策者和领域专业人员的关注,并激发进一步的研究。因此,我们试图确定有关防止PA阶段错误所需的干预和实践的阈值成本。
{"title":"Direct cost analysis for 32,783 samples with preanalytical phase errors.","authors":"Pinar Eker","doi":"10.14744/nci.2022.73555","DOIUrl":"https://doi.org/10.14744/nci.2022.73555","url":null,"abstract":"<p><strong>Objective: </strong>Errors in the laboratory process often occur in the preanalytical phase (PA). The study aims to calculate the direct cost elements of PA errors, including material, logistics, transfer, personnel workforce, and medical waste.</p><p><strong>Methods: </strong>Medical laboratory PA phase errors were retrospectively reviewed using the Laboratory Information Management System. We evaluated the whole 2019 laboratory data of the 836-bed Health Sciences University Umraniye Training and Research Hospital (UTRH). We assessed the direct cost elements of PA errors, such as those related to material, logistics, transfer, human resources, and waste. We performed the procedure for both samples analyzed in the hospital and transferred to the central laboratory.</p><p><strong>Results: </strong>We analyzed 1,939,650 patient samples and 46,534,532 parameters studied in 2019 for UTRH. The rates for rejected tests and rejected samples (tube) for UTRH were noted as 0.32% and 1.7%, respectively. The total direct cost for PA errors was TRY 438,284.51 (68,918.07 euros) for 32,783 patient samples and 147,893 tests. We calculated the total cost for PA test errors detected in the hospital as TRY 390,238.06, while the total cost for PA test errors detected in the central laboratory was TRY 48,046.45. 89% of the total cost was for PA errors detected in the hospital, and 11% was for the errors detected in the central laboratory. The 2019 direct PA error cost we calculated based on our hospital's data was 0.153% of the 2019 hospital operating cost. We calculated the direct cost per rejected sample as TRY 13.37 (2.1 Euro).</p><p><strong>Conclusion: </strong>Providing reliable laboratory service with the least possible financial loss is one of the main goals in terms of laboratory medicine. In achieving this goal, the prevention of error costs is a priority. The direct cost elements for the PA phase, where laboratory errors are concentrated, can be easily identified. The amount of PA phase error direct cost will attract the attention of health policy decision-makers and field professionals and inspire further research. Therefore, we tried to determine a threshold cost regarding interventions and practices required to prevent PA phase errors.</p>","PeriodicalId":19164,"journal":{"name":"Northern Clinics of Istanbul","volume":"9 4","pages":"391-400"},"PeriodicalIF":1.0,"publicationDate":"2022-09-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/a6/95/NCI-9-391.PMC9514066.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40565415","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Accuracy of magnetic resonance imaging in assessing knee cartilage changes over time in patients with osteoarthritis: A systematic review. 磁共振成像评估骨关节炎患者膝关节软骨随时间变化的准确性:一项系统综述。
IF 1 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2022-09-05 eCollection Date: 2022-01-01 DOI: 10.14744/nci.2021.34270
Yashar Hashemi Aghdam, Amin Moradi, Lars Gerhard Großterlinden, Morteza Seyed Jafari, Johannes T Heverhagen, Keivan Daneshvar

Magnetic resonance imaging (MRI) is a technique useful for the diagnosis of cartilage damage due to high sensitivity to identify subchondral bone abnormalities and full-thickness cartilage lesions. The lack of a study on knee cartilage changes over time in patients with osteoarthritis (OA) by MRI technique led us to investigate the accuracy of MRI in identifying knee cartilage changes over time in patients with OA in a systematic review. In the present systematic review, started from the beginning of 2020 in one of the University Hospitals in Iran, the databases of CINAHL, Ovid, Elsevier, Scopus, PubMed, Science Direct, and Web of Science were searched using the keywords MRI, OA, Cartilage Lesion, Imaging Techniques. A total of 169 articles were retrieved in the initial search, and after reviewing the titles, abstracts, and full-texts, finally, seven were enrolled in the systematic review. Review of the selected papers showed that a total of 1091 subjects were studied, of which 355 were males. The results of all the studies, except one, indicated the high accuracy of MRI to identify knee cartilage changes over time. MRI technique can show cartilage changes with high accuracy in patients with knee OA over time. We proved the potential of MRI to identify articular cartilage injuries in patients with OA and its importance to the evaluation of articular cartilage lesions along with other available techniques.

磁共振成像(MRI)是一种诊断软骨损伤的技术,因为它对识别软骨下骨异常和全层软骨病变具有很高的灵敏度。由于缺乏通过MRI技术对骨关节炎(OA)患者膝关节软骨随时间变化的研究,因此我们在一项系统综述中研究了MRI识别OA患者膝关节软骨随时间变化的准确性。本系统综述从2020年初开始,在伊朗的一所大学医院中,使用关键词MRI, OA,软骨病变,成像技术检索CINAHL, Ovid, Elsevier, Scopus, PubMed, Science Direct和Web of Science数据库。初始检索共检索到169篇文献,在对标题、摘要、全文进行检索后,最终纳入7篇文献。回顾所选论文,共研究了1091名受试者,其中男性355名。除了一项研究外,所有研究的结果都表明,MRI在识别膝关节软骨随时间变化的准确性很高。随着时间的推移,MRI技术可以高精度地显示膝关节OA患者的软骨变化。我们证明了MRI识别OA患者关节软骨损伤的潜力,以及它与其他可用技术一起评估关节软骨病变的重要性。
{"title":"Accuracy of magnetic resonance imaging in assessing knee cartilage changes over time in patients with osteoarthritis: A systematic review.","authors":"Yashar Hashemi Aghdam,&nbsp;Amin Moradi,&nbsp;Lars Gerhard Großterlinden,&nbsp;Morteza Seyed Jafari,&nbsp;Johannes T Heverhagen,&nbsp;Keivan Daneshvar","doi":"10.14744/nci.2021.34270","DOIUrl":"https://doi.org/10.14744/nci.2021.34270","url":null,"abstract":"<p><p>Magnetic resonance imaging (MRI) is a technique useful for the diagnosis of cartilage damage due to high sensitivity to identify subchondral bone abnormalities and full-thickness cartilage lesions. The lack of a study on knee cartilage changes over time in patients with osteoarthritis (OA) by MRI technique led us to investigate the accuracy of MRI in identifying knee cartilage changes over time in patients with OA in a systematic review. In the present systematic review, started from the beginning of 2020 in one of the University Hospitals in Iran, the databases of CINAHL, Ovid, Elsevier, Scopus, PubMed, Science Direct, and Web of Science were searched using the keywords MRI, OA, Cartilage Lesion, Imaging Techniques. A total of 169 articles were retrieved in the initial search, and after reviewing the titles, abstracts, and full-texts, finally, seven were enrolled in the systematic review. Review of the selected papers showed that a total of 1091 subjects were studied, of which 355 were males. The results of all the studies, except one, indicated the high accuracy of MRI to identify knee cartilage changes over time. MRI technique can show cartilage changes with high accuracy in patients with knee OA over time. We proved the potential of MRI to identify articular cartilage injuries in patients with OA and its importance to the evaluation of articular cartilage lesions along with other available techniques.</p>","PeriodicalId":19164,"journal":{"name":"Northern Clinics of Istanbul","volume":"9 4","pages":"414-418"},"PeriodicalIF":1.0,"publicationDate":"2022-09-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/1a/2c/NCI-9-414.PMC9514082.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40565417","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
A randomized controlled trial to study the effect of intratracheal and intravenous lignocaine on airway and hemodynamic response during emergence and extubation following general anesthesia. 一项随机对照试验,研究全身麻醉后急诊和拔管时气管内和静脉注射利多卡因对气道和血流动力学反应的影响。
IF 1 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2022-09-05 eCollection Date: 2022-01-01 DOI: 10.14744/nci.2021.33407
Divya V Gladston, Sudha Padmam, Rajasree Omanakutty Amma, Rachel Cherian Koshy, K M Jagathnath Krishna, Jayasree Vijayan, Nimmy George, Praveen Rajendran

Objective: Intratracheal (IT) and intravenous (IV) lignocaine suppress airway reflex and hemodynamic response during extubation, but studies regarding this are sparse. The primary aim was to compare the effect of IT and IV lignocaine on attenuation of airway reflex to endotracheal extubation and the secondary aim was to compare the hemodynamic responses to extubation, using lignocaine by the two different routes.

Methods: Seventy-five female patients with comparable age, body mass index, and American Society of Anesthesiologists Physical Status undergoing carcinoma breast surgery were randomized into three groups. Group A received 2% lignocaine 3 mg/kg intratracheally 5 min and Group B received 2% lignocaine 1.5 mg/kg intravenously 3 min before extubation. Group C was control group. The airway and hemodynamic responses were noted in terms of episodes of cough during emergence and extubation. Categorical variables assessed using Fisher's exact test and continuous variables assessed using one-way analysis of variance.

Results: Cough suppression was present in Groups A and B, with better results observed with IT than with IV lignocaine. In the control group, Grade III cough reflex was present predominantly. There was a statistically significant difference (p<0.001) in blood pressure and heart rate between Group A versus Group C and in Group B versus Group C, but not between Group A and Group B.

Conclusion: IT lignocaine administered before extubation significantly attenuates post-extubation cough reflex than IV lignocaine. Both IT and IV lignocaine can effectively attenuate the airway and hemodynamic response to extubation.

目的:利多卡因气管内(IT)和静脉内(IV)抑制拔管时气道反射和血流动力学反应,但相关研究较少。主要目的是比较静脉注射和静脉注射利多卡因对气管内拔管时气道反射衰减的影响,次要目的是比较两种不同途径使用利多卡因拔管时的血流动力学反应。方法:75例年龄、体重指数和美国麻醉医师协会体质状况相当的女性乳腺癌手术患者随机分为三组。A组在拔管前5min,静脉滴注2%利多卡因3 mg/kg, B组在拔管前3min,静脉滴注2%利多卡因1.5 mg/kg。C组为对照组。气道和血流动力学反应被记录在急诊和拔管期间的咳嗽发作。分类变量使用Fisher精确检验评估,连续变量使用单向方差分析评估。结果:A组和B组均有止咳作用,且应用IT组止咳效果优于静脉注射利多卡因组。对照组以III级咳嗽反射为主。结论:拔管前给予利多卡因比静脉注射利多卡因能明显减轻拔管后咳嗽反射。体外注射和静脉注射利多卡因均能有效减弱拔管后气道和血流动力学反应。
{"title":"A randomized controlled trial to study the effect of intratracheal and intravenous lignocaine on airway and hemodynamic response during emergence and extubation following general anesthesia.","authors":"Divya V Gladston,&nbsp;Sudha Padmam,&nbsp;Rajasree Omanakutty Amma,&nbsp;Rachel Cherian Koshy,&nbsp;K M Jagathnath Krishna,&nbsp;Jayasree Vijayan,&nbsp;Nimmy George,&nbsp;Praveen Rajendran","doi":"10.14744/nci.2021.33407","DOIUrl":"https://doi.org/10.14744/nci.2021.33407","url":null,"abstract":"<p><strong>Objective: </strong>Intratracheal (IT) and intravenous (IV) lignocaine suppress airway reflex and hemodynamic response during extubation, but studies regarding this are sparse. The primary aim was to compare the effect of IT and IV lignocaine on attenuation of airway reflex to endotracheal extubation and the secondary aim was to compare the hemodynamic responses to extubation, using lignocaine by the two different routes.</p><p><strong>Methods: </strong>Seventy-five female patients with comparable age, body mass index, and American Society of Anesthesiologists Physical Status undergoing carcinoma breast surgery were randomized into three groups. Group A received 2% lignocaine 3 mg/kg intratracheally 5 min and Group B received 2% lignocaine 1.5 mg/kg intravenously 3 min before extubation. Group C was control group. The airway and hemodynamic responses were noted in terms of episodes of cough during emergence and extubation. Categorical variables assessed using Fisher's exact test and continuous variables assessed using one-way analysis of variance.</p><p><strong>Results: </strong>Cough suppression was present in Groups A and B, with better results observed with IT than with IV lignocaine. In the control group, Grade III cough reflex was present predominantly. There was a statistically significant difference (p<0.001) in blood pressure and heart rate between Group A versus Group C and in Group B versus Group C, but not between Group A and Group B.</p><p><strong>Conclusion: </strong>IT lignocaine administered before extubation significantly attenuates post-extubation cough reflex than IV lignocaine. Both IT and IV lignocaine can effectively attenuate the airway and hemodynamic response to extubation.</p>","PeriodicalId":19164,"journal":{"name":"Northern Clinics of Istanbul","volume":"9 4","pages":"323-330"},"PeriodicalIF":1.0,"publicationDate":"2022-09-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/a7/4d/NCI-9-323.PMC9514071.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40676056","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Northern Clinics of Istanbul
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1